October 24, 2025
National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051. Symbol: STAR | BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001. Scrip Code: 532531 |
Dear Madam/ Sir,
Sub: Intimation regarding Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Friday, October 31, 2025, to consider and approve the un-audited financial results (standalone and consolidated) of the Company for the quarter and half year ended September 30, 2025, amongst other matters.
Further, as per provisions of the Company's Code of Conduct for Prohibition of Insider Trading, trading window for Designated Persons of the Company is closed from October 1, 2025 and shall open after 48 hours post declaration of financial results by the Company.
The above information will also be available on website of the Company at https://www.strides.com.
This is for your kind information and record purposes. Thanks & Regards,
For Strides Pharma Science Limited,
MANJULA
Digitally signed by MANJULA RAMAMURTHY
+05'30'
RAMAMURTHY Date: 2025.10.24 18:34:40
Manjula Ramamurthy Company Secretary & Compliance Officer ICSI Membership No.: A30515 Strides Pharma Science LimitedCIN: L24230MH1990PLC057062
Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru - 560 076, India Tel: +91-80-6784 0000 Fax: +91 80 6784 0700 Regd Off: 'Cyber One', Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703, India Tel: +91-22-2789 2924/ 3199corpcomm@strides.com; https://www.strides.com